现金流量表（Iovance Biotherapeutics Inc）
| 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 起始日期 | 2024-01-01 | 2024-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 经营活动产生的现金流量： | ||||||||||
| 净利润(元) | -210,077,000.00 | -112,976,000.00 | -444,037,000.00 | -327,658,000.00 | -213,898,000.00 | -107,370,000.00 | -395,893,000.00 | -290,574,000.00 | -190,956,000.00 | -91,607,000.00 |
| 折旧及摊销(元) | 20,771,000.00 | 9,907,000.00 | 33,127,000.00 | 23,413,000.00 | 13,538,000.00 | 5,697,000.00 | 21,135,000.00 | 15,428,000.00 | 11,221,000.00 | 5,833,000.00 |
| 基于股票的补偿费(元) | 47,644,000.00 | 17,178,000.00 | 62,625,000.00 | 48,226,000.00 | 32,405,000.00 | 15,665,000.00 | 84,022,000.00 | 64,513,000.00 | 44,733,000.00 | 22,265,000.00 |
| 减值及拨备(元) | - | - | - | - | - | - | 397,000.00 | 314,000.00 | 314,000.00 | - |
| 递延所得税(元) | -2,866,000.00 | -1,408,000.00 | -3,479,000.00 | -1,720,000.00 | -477,000.00 | - | - | - | - | - |
| 汇兑损益(元) | -86,000.00 | -96,000.00 | 70,000.00 | 176,000.00 | -181,000.00 | - | - | - | - | - |
| 经营业务调整其他项目(元) | -4,834,000.00 | -2,335,000.00 | -3,605,000.00 | -1,878,000.00 | -855,000.00 | -978,000.00 | 474,000.00 | 1,128,000.00 | - | - |
| 存货的减少(增加)(元) | -15,594,000.00 | -6,735,000.00 | -10,118,000.00 | -9,195,000.00 | -9,549,000.00 | - | - | - | - | - |
| 预付款项及其他应收款减少(增加)(元) | 5,677,000.00 | 5,888,000.00 | -10,062,000.00 | -4,914,000.00 | -7,065,000.00 | -4,231,000.00 | -2,130,000.00 | - | - | - |
| 待摊费用及其他资产(元) | - | - | - | - | - | - | - | -4,976,000.00 | -2,661,000.00 | -3,715,000.00 |
| 应收账款及票据减少(增加)(元) | -31,453,000.00 | -83,000.00 | -149,000.00 | - | -33,000.00 | - | - | - | - | - |
| 应付账款及票据增加(减少)(元) | -16,205,000.00 | -5,815,000.00 | 4,828,000.00 | -6,595,000.00 | 3,171,000.00 | 3,025,000.00 | 5,883,000.00 | 4,327,000.00 | 65,000.00 | -2,104,000.00 |
| 应计费用及其他负债(元) | -8,207,000.00 | -23,015,000.00 | 19,774,000.00 | 10,369,000.00 | -5,562,000.00 | -9,054,000.00 | -4,703,000.00 | -5,612,000.00 | -15,055,000.00 | -5,164,000.00 |
| 经营业务其他项目(元) | -5,478,000.00 | -2,789,000.00 | -10,794,000.00 | -8,074,000.00 | -5,261,000.00 | -2,569,000.00 | -1,942,000.00 | 366,000.00 | 902,000.00 | 690,000.00 |
| 经营活动产生的现金流量净额(元) | -220,708,000.00 | -122,279,000.00 | -361,820,000.00 | -277,850,000.00 | -193,767,000.00 | -99,815,000.00 | -292,757,000.00 | -215,086,000.00 | -151,437,000.00 | -73,802,000.00 |
| 投资活动产生的现金流量： | ||||||||||
| 购买固定资产支付的现金(元) | -4,613,000.00 | -4,171,000.00 | -22,290,000.00 | -18,761,000.00 | -15,184,000.00 | -5,664,000.00 | -20,425,000.00 | -17,403,000.00 | -16,016,000.00 | -11,440,000.00 |
| 购买无形资产及其他资产支付的现金(元) | - | - | - | - | - | - | - | - | 198,295,000.00 | 97,956,000.00 |
| 投资支付现金(元) | -216,101,000.00 | -141,762,000.00 | -205,902,000.00 | -98,333,000.00 | -5,323,000.00 | -5,323,000.00 | -245,816,000.00 | -150,189,000.00 | - | - |
| 收购附属公司(元) | -52,573,000.00 | - | -212,633,000.00 | -212,886,000.00 | -209,509,000.00 | - | - | - | - | - |
| 投资业务其他项目(元) | 202,000,000.00 | 34,427,000.00 | 285,583,000.00 | 247,583,000.00 | 226,633,000.00 | 164,383,000.00 | 522,696,000.00 | 423,586,000.00 | - | - |
| 投资活动产生的现金流量净额(元) | -71,287,000.00 | -111,506,000.00 | -155,242,000.00 | -82,397,000.00 | -3,383,000.00 | 153,396,000.00 | 256,455,000.00 | 255,994,000.00 | 182,279,000.00 | 86,516,000.00 |
| 融资活动产生的现金流量： | ||||||||||
| 发行股份(元) | 352,102,000.00 | 198,277,000.00 | 465,754,000.00 | 464,606,000.00 | 261,427,000.00 | 260,101,000.00 | 192,799,000.00 | 2,224,000.00 | 1,417,000.00 | 1,417,000.00 |
| 回购股份(元) | - | - | - | - | - | - | - | - | 582,000.00 | - |
| 筹资业务其他项目(元) | -5,701,000.00 | -4,701,000.00 | -2,795,000.00 | -2,609,000.00 | -2,230,000.00 | -1,929,000.00 | -2,649,000.00 | -2,649,000.00 | -2,649,000.00 | - |
| 融资活动产生的现金流量净额(元) | 346,401,000.00 | 193,576,000.00 | 462,959,000.00 | 461,997,000.00 | 259,197,000.00 | 258,172,000.00 | 190,150,000.00 | -425,000.00 | -650,000.00 | 1,417,000.00 |
| 汇率变动影响(元) | -616,000.00 | -491,000.00 | -2,740,000.00 | -5,761,000.00 | -3,768,000.00 | - | - | - | - | - |
| 现金及现金等价物期初余额(元) | 181,318,000.00 | 181,318,000.00 | 238,161,000.00 | 238,161,000.00 | 238,161,000.00 | 238,161,000.00 | 84,313,000.00 | 84,313,000.00 | 84,313,000.00 | 84,313,000.00 |
| 现金及现金等价物增加(减少)额(元) | 53,790,000.00 | -40,700,000.00 | -56,843,000.00 | 95,989,000.00 | 58,279,000.00 | 311,753,000.00 | 153,848,000.00 | 40,483,000.00 | 30,192,000.00 | 14,131,000.00 |
| 现金及现金等价物期末余额(元) | 235,108,000.00 | 140,618,000.00 | 181,318,000.00 | 334,150,000.00 | 296,440,000.00 | 549,914,000.00 | 238,161,000.00 | 124,796,000.00 | 114,505,000.00 | 98,444,000.00 |
| 补充资料其他项目(元) | 37,085,000.00 | 29,958,000.00 | 228,849,000.00 | 229,470,000.00 | 231,310,000.00 | 8,902,000.00 | 21,541,000.00 | 8,406,000.00 | - | - |
| 非现金活动(元) | - | - | - | - | - | - | - | - | - | 10,831,000.00 |
| 公告日期 | 2024-08-08 | 2024-05-09 | 2024-02-28 | 2023-11-07 | 2023-08-08 | 2023-05-10 | 2023-02-28 | 2022-11-03 | 2022-08-04 | 2022-05-05 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||||
| 核数师 |